← All Dossiers
Vortex Bio — Pre-Round
In Conversation Fund: StoryHouse Fund II
Dossier generated 2026-06-16 by /deal-dossier  ·  Deal record: recLzypXHTvOJ9oJ7  ·  Source: Airtable appjxAR3LPe3fkHOp

One-Liner & Thesis

AI protein engineering company, KGI-alumna founded, at the pre-formation stage. Vortex Bio surfaced this week via an inbound LinkedIn from founder Karen Paco; the company is currently a founder-plus-concept, with no shared deck, traction, or technical detail in the file yet.

The relevant signals at this point are the inbound itself and the KGI tie — a network in which StoryHouse has strong founder-quality priors. No round terms or capital sought. SH stance is a fast first call to evaluate team, approach, and whether there is a real wedge underneath the category label; this is on the Fund II tracking list, not yet an underwriting candidate.

Deal Box

Funding Round
Pre-Round
Fund
StoryHouse Fund II

Founders

Karen Paco
Founder, Vortex Bio
KGI alumna. Recently founded Vortex Bio, positioned as an AI protein engineering company. Reached out to StoryHouse via LinkedIn to explore resources and support for early founders; no public background detail beyond the KGI tie has been collected in the file yet.

Open Questions & Risks

Next Steps

Latest Meeting Notes

2026-06-15 Inbound Inbound LinkedIn from KGI alumna founder

Cold LinkedIn message from Karen Paco introducing herself as the founder of Vortex Bio, an AI protein engineering company, and asking to learn about StoryHouse resources for early founders.

Source: Meeting Notes recHtJwPrZqPfllrj

Deal Timeline